Duloxetine
Links shared publicly online about this topic
Duloxetine: In Patients with Fibromyalgia : Drugs
drugs.adisonline.com — “[black up pointing small triangle] Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor available in delayed-release capsules for oral use. [black up pointing small triangle] Duloxetine 60 mg/day, compared with placebo, was associated with a greater reduction from baseline in t” View full resource at drugs.adisonline.com
Most Recently Shared on June 26, 2009 at 6:10 pm By:
Duloxetine: In Patients with Fibromyalgia. http://tinyurl.com/kpj3le
Duloxetine, Pregabalin, and Duloxetine + Gabapentin Safe for Diabetic Peripheral Neuropathic Pain - ONA
oncologynurseadvisor.com — “Duloxetine, pregabalin, and duloxetine + gabapentin were found to be safe and tolerable for the treatment of diabetic peripheral neuropathic pain, according to results presented today at the American Pain Society--™s 30th Annual Scientific Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 19, 2011 at 8:49 pm By:
Duloxetine, Pregabalin, and Duloxetine + Gabapentin Safe for Diabetic Peripheral Neuropathic… http://goo.gl/fb/NlvjJ
Duloxetine, Pregabalin, and Duloxetine + Gabapentin Safe for Diabetic Peripheral Neuropathic Pain - MPR
empr.com — “Duloxetine, pregabalin, and duloxetine + gabapentin were found to be safe and tolerable for the treatment of diabetic peripheral neuropathic pain, according to results presented today at the American Pain Society--™s 30th Annual Scientific Meeting.” View full resource at empr.com
Most Recently Shared on May 19, 2011 at 9:23 pm By:
MPR News: Duloxetine, Pregabalin, and Duloxetine + Gabapentin Safe for Diabetic Peripheral Neuropathic Pain: Dul... http://bit.ly/iRy5HX
IngentaConnect Duloxetine: In Patients with Fibromyalgia
ingentaconnect.com — “IngentaConnect Duloxetine: In Patients with Fibromyalgia” View full resource at ingentaconnect.com
Most Recently Shared on June 23, 2009 at 7:37 pm By:
Duloxetine: In Patients with Fibromyalgia http://tinyurl.com/ljrmb2
www.HealthGuru.com: Cymbalta (Duloxetine)
healthguru.com — “A pharmacist explains how Cymbalta works, why doctors prescribe this antidepressant, and common side effects of the drug.” View full resource at healthguru.com
Most Recently Shared on May 14, 2010 at 7:49 pm By:
You've seen the commercials: "Depression hurts. Cymbalta can help." How? Pharmacist explains: http://su.pr/1OXtew
Cymbalta (duloxetine) Drug Information by MedicineNet.com
medicinenet.com — “Read about Cymbalta (duloxetine), a drug prescribed for neuropathic pain associated with diabetic peripheral neuropathy, depression, and anxiety. Side effect, dosage, and drug interaction information included.” View full resource at medicinenet.com
Most Recently Shared on January 7, 2012 at 5:45 am By:
duloxetine, Cymbalta: Title: duloxetine, CymbaltaCategory: MedicationsCreated: 7/11/2007Last Edito... http://t.co/WGFk49xd #mentalhealth
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications
medicalnewstoday.com — “The Anesthetic and Life Support Drugs Advisory Committee which advises the FDA on whether to approve new drugs or alter their indications, has voted 8-6 in favor of expanding pain indications for” View full resource at medicalnewstoday.com
Most Recently Shared on August 20, 2010 at 11:33 am By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications http://mnt.to/3HDZ #healthnews
"Tako-Tsubo" Cardiomyopathy and Duloxetine Use - QualityPoint Technologies
qualitypointtech.net — “Was the potent SNRI duloxetine a precipitating factor in this patient's tako-tsubo cardiomyopathy? Southern Medical Journal” View full resource at qualitypointtech.net
Most Recently Shared on May 20, 2011 at 11:00 am By:
"Tako-Tsubo" Cardiomyopathy and Duloxetine Use: Was the potent SNRI duloxetine a precipitating factor in... http://bit.ly/ikZ96J
Nursing Medical News about Chronic Disease Pain Duloxetine
mdlinx.com — “Duloxetine: A Review of its Pharmacology and Use in Chronic Pain Management” View full resource at mdlinx.com
Most Recently Shared on May 13, 2010 at 7:44 am By:
Duloxetine: A Review of its Pharmacology and Use in Chronic Pain Management: Regional Anesthesia and Pain ... http://bit.ly/b8lzNi #Nursing
Duloxetine Safe, Effective, in Patients with Chronic Low Back Pain - MPR
empr.com — “Duloxetine 60 mg once daily was effective in reducing chronic low back pain compared with placebo, results of a phase III randomized, double-blind study have shown according to data presented at the American Pain Society's 29th Annual Scientific Meeting. Perception of improvement was also significantly greater among patients receiving duloxetine.” View full resource at empr.com
Most Recently Shared on May 8, 2010 at 2:42 pm By:
APS: Duloxetine Safe, Effective, in Patients with Chronic Low Back Pain: Duloxetine 60 mg once daily was effective... http://bit.ly/a4JeuQ
Equivocal Message on Duloxetine for Pain from Panel - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- BETHESDA, Md. " An FDA advisory committee has voted narrowly " 8 to 6 " to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 10:45 pm By:
Equivocal Message on Duloxetine for Pain from Panel: (MedPage Today) -- BETHESDA, Md. — An FDA advisory committe... http://bit.ly/bD6tYP
Bipolar Disorder Medication Spotlight: Cymbalta (Duloxetine) | Bipolar Beat
zz.gd — “With this post, we continue our sort-of-biweekly series on medications used to treat bipolar disorder and related symptoms. A few weeks ago, we began our” View full resource at zz.gd
Most Recently Shared on June 5, 2009 at 2:06 pm By:
Bipolar Beat: Bipolar Disorder Medication Spotlight: Cymbalta (Duloxetine) @http://zz.gd/4b498c
Rheumatology Medical News about Depressive Disorder, Major Fibromyalgia; duloxetine
mdlinx.com — “Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: Secondary analyses of four pooled randomized controlled trials of duloxetine” View full resource at mdlinx.com
Most Recently Shared on July 6, 2010 at 2:26 pm By:
Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorde... http://bit.ly/9x24sL #Rheumatology
Family Med Medical News about Depressive Disorder, Major Fibromyalgia; duloxetine
mdlinx.com — “Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: Secondary analyses of four pooled randomized controlled trials of duloxetine” View full resource at mdlinx.com
Most Recently Shared on July 6, 2010 at 8:10 am By:
Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder:... http://bit.ly/b76wm8 #GM #mdlinx
Google Sidewiki entry about Cymbalta (duloxetine HCl): Official Site
google.com — “First Cymbalta was approved for GAD (generalized anxiety disorder), then the buzz machine went into action to imply that Cymbalta can cure back pain! What next? No wonder Cymbalta was #5 among the TOP 20 DTC advertisers in Q1 2009, spending $39.3 million that quarter. See these Pharma Marketing Blog posts: eGAD! How I Learned to Stop Worrying and Love Cymbalta! <” View full resource at google.com
Most Recently Shared on October 5, 2009 at 5:18 pm By:
Just wrote a Sidewiki entry on "Cymbalta Official Site" http://bit.ly/ylsMx What isn't it good for? #5 TOP DTC spender in Q1 2009.
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement

